Prevail Therapeutics to Present at Morgan Stanley 2019 Global Healthcare Conference
The live webcast will be available in the investor section of the company's website at www.prevailtherapeutics.com. The webcast will be archived for 90 days following the presentation.
Prevail is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. Prevail was founded by Dr.
Katie Engleman1AB katie@1ABmedia.com Investor Contact: firstname.lastname@example.org
Source: Prevail Therapeutics